HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The metastatic tumor antigen 1-transglutaminase-2 pathway is involved in self-limitation of monosodium urate crystal-induced inflammation by upregulating TGF-β1.

AbstractINTRODUCTION:
Transglutaminase 2 (TG2), a protein crosslinking enzyme with multiple biochemical functions, has been connected to various inflammatory processes. In this study, the involvement of TG2 in monosodium urate (MSU) crystal-induced inflammation was studied.
METHODS:
Immunohistochemistry, reverse transcription-polymerase chain reaction (RT-PCR) were performed to detect TG2 expression in synovial fluid mononuclear cells (SFMCs) and synovial tissue from patients with gouty arthritis. MSU crystal-exposed RAW264.7 mouse macrophages were analyzed for interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), transforming growth factor β1 (TGF-β1) and TG2 expression by RT-PCR and enzyme-linked immunosorbent assay (ELISA). TG2 small interfering (si)-RNA-mediated silencing and overexpression in RAW264.7 cells were used to evaluate the involvement of TG2 in resolving MSU crystal-induced inflammation. The role of metastatic tumor antigen 1 (MTA1), a master chromatin modifier, was investigated by MTA1 si-RNA-mediated knockdown. In addition, the inflammatory responses were followed in wild type and TG2 null mice after being challenged with MSU crystals in an in vivo peritonitis model.
RESULTS:
TG2 expression was up-regulated in the synovium tissue and SFMCs from patients with gouty arthritis. The levels of MTA1, TG2, TGF-β1, IL-1β and TNF-α mRNAs were consistently increased in MSU crystal-stimulated RAW264.7 cells. si-MTA1 impaired the basal, as well as the MSU crystal-induced expression of TG2 and TGF-β1, but increased that of IL-1β and TNF-α. TG2 overexpression dramatically suppressed MSU crystal-induced IL-1β and TNF-α, but significantly enhanced the TGF-β1 production. Neutralizing TGF-β antibodies or inhibition of the crosslinking activity of TG2 attenuated these effects. On the contrary, loss of TG2 resulted in a reduced TGF-β, but in an increased IL-1β and TNF-α production in MSU crystal-stimulated RAW264.7 cells and mouse embryonic fibroblasts (MEFs). MSU crystal-stimulated IL-1β production was Janus kinase 2 (JAK2)-signaling dependent and TG2-induced TGF-β suppressed the activity of it. Finally, TG2-deficient mice exhibited hyper inflammatory responses after being challenged with MSU crystals in an in vivo peritonitis model.
CONCLUSIONS:
These findings reveal an inherent regulatory role of the MTA1-TG2 pathway in the self-limitation of MSU crystal-induced inflammation via positively regulating the levels of active TGF-β1 in macrophages that opposes the MSU crystal-induced JAK2-dependent pro-inflammatory cytokine formation.
AuthorsJia-Hau Yen, Ling-Chung Lin, Meng-Chi Chen, Zsolt Sarang, Pui-Ying Leong, I-Chang Chang, Jeng-Dong Hsu, Jiunn-Horng Chen, Yu-Fan Hsieh, Anna Pallai, Krisztina Köröskényi, Zsuzsa Szondy, Gregory J Tsay
JournalArthritis research & therapy (Arthritis Res Ther) Vol. 17 Pg. 65 (Mar 19 2015) ISSN: 1478-6362 [Electronic] England
PMID25889736 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Mta1 protein, human
  • Repressor Proteins
  • Trans-Activators
  • Transforming Growth Factor beta1
  • Uric Acid
  • Protein Glutamine gamma Glutamyltransferase 2
  • Transglutaminases
  • Histone Deacetylases
  • GTP-Binding Proteins
Topics
  • Animals
  • Arthritis, Gouty (metabolism, pathology)
  • Cell Line
  • GTP-Binding Proteins (biosynthesis)
  • Histone Deacetylases (biosynthesis)
  • Humans
  • Inflammation (metabolism, pathology)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Protein Glutamine gamma Glutamyltransferase 2
  • Repressor Proteins (biosynthesis)
  • Trans-Activators
  • Transforming Growth Factor beta1 (biosynthesis)
  • Transglutaminases (biosynthesis)
  • Up-Regulation (drug effects, physiology)
  • Uric Acid (toxicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: